US 12,227,469 B2
Disulfiram derivatives as ALDH1a1 and MAGL inhibitors
Ziad Omran, Jeddah (SA); and Omeima Abdullah, Makkah (SA)
Assigned to BATTERJEE MEDICAL COLLEGE, Jeddah (SA)
Filed by BATTERJEE MEDICAL COLLEGE, Jeddah (SA)
Filed on Dec. 5, 2022, as Appl. No. 18/075,163.
Application 18/075,163 is a division of application No. 17/540,826, filed on Dec. 2, 2021.
Prior Publication US 2023/0174475 A1, Jun. 8, 2023
Int. Cl. C07C 333/26 (2006.01); C07D 401/12 (2006.01); C07D 409/12 (2006.01)
CPC C07C 333/26 (2013.01) [C07D 401/12 (2013.01); C07D 409/12 (2013.01)] 14 Claims
 
1. A disulfiram derivative of formula (I),

OG Complex Work Unit Chemistry
optionally as a salt, solvate, tautomer, stereoisomer, or mixture thereof,
wherein R1 and R2 are independently CH2CH2COOEt, methylenepyridyl, or methylenefuranyl.